Assistance Options for Your Eligible Patients

Several options are available to help eligible patients with the out-of-pocket (OOP) costs of ROZLYTREK™.

Find the right patient assistance option for your patient using the Patient Assistance Tool.

  • Is your patient insured?

  • Does the patient's insurance cover his or her Genentech medicine?

  • Does your patient have commercial insurance?

    What does this mean?
  • Has your patient already been referred to the Genentech BioOncology Co-pay Card and is either ineligible or no longer receiving assistance?

  • Has your patient already been referred to an independent co-pay assistance foundation and is either ineligible or no longer receiving assistance?

  • Is the patient 18 years of age or older?

Your Patient Might Qualify for a Referral to the Genentech BioOncology Co-pay Assistance Program

If eligible commercially insured patients need assistance with their out-of-pocket costs for ROZLYTREK and/or associated NTRK gene fusion diagnostic testing, Genentech BioOncology® Access Solutions for ROZLYTREK can refer them to the Genentech BioOncology Co-pay Assistance Program.

 

Learn More

Your Patient Might Qualify for a Referral to an Independent Co-pay Assistance Foundation

For eligible patients with commercial or public health insurance, Genentech BioOncology® Access Solutions for ROZLYTREK offers referrals to independent co-pay assistance foundations.*

 

Learn More

 

*Genentech does not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from Genentech BioOncology Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech’s endorsement or financial support. There may be other foundations to support the patient's disease state.

Your Patient Might Qualify for a Referral to the Genentech Patient Foundation

The Genentech Patient Foundation provides free Genentech medicine to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.*

 

Learn More

 

*To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine must have exhausted all other forms of patient assistance (including the Genentech BioOncology Co-pay Assistance Program and support from independent co-pay assistance foundations) and must meet financial criteria. Uninsured patients and insured patients without coverage for their medicine must meet different financial criteria.

Does your patient have commercial insurance

Does Your Patient Have Commercial Insurance?

Genentech BioOncology® Access Solutions can refer eligible patients to the ROZLYTREK Co-pay Program* for help with the OOP cost associated with ROZLYTREK and/or NTRK gene fusion testing.†

Does your patient have insurance

Does Your Patient Have Insurance?

If eligible publicly or commercially insured patients have difficulty paying for their co-pay, co-insurance or other OOP costs, Genentech BioOncology Access Solutions can refer them to an independent co-pay assistance foundation supporting their disease state.

Does your patient have no insurance or have financial concerns

Does Your Patient Have No Insurance or Have Financial Concerns?

The Genentech Patient Foundation helps people affected by serious medical conditions get the ROZLYTREK they have been prescribed. People who do not have health insurance, who have health insurance that does not cover their ROZLYTREK, or who can't afford their OOP costs may get free medicine.§

Is your patient awaiting coverage determination

Is Your Patient Awaiting Coverage Determination?

With ROZLYTREK SureStart® Program, eligible patients taking ROZLYTREK may receive free medicine while awaiting an insurance coverage determination.

*This Genentech BioOncology Co-pay Assistance Program is valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid, or any other federal or state government program to pay for their medications are not eligible.
Under the Program, the patient will pay a co-pay. After reaching the maximum Program benefit, the patient will be responsible for all out-of-pocket costs.
All participants are responsible for reporting the receipt of all Program benefits as required by any insurer or by law. No party may seek reimbursement for all or any part of the benefit received through this Program. This Program is void where prohibited by law. Genentech reserves the right to rescind, revoke, or amend the Program without notice at any time. Additional eligibility criteria apply. See full terms and conditions at CopayAssistanceNow.com.

Under the Program, the patient will pay a co-pay. After reaching the maximum per treatment or annual limit the patient will be responsible for all remaining pay Out-of-Pocket expenses. The amount of the Program benefit cannot exceed the patient’s Out-of-Pocket expenses for the cost of administrative fees associated with ROZLYTREK.
Patients using Medicare, Medicaid or any other federal or state government funded program to pay for their medications or associated Testing Reimbursement fees are not eligible. Patients who start utilizing their Government Program during their enrollment period will no longer be eligible for the Program. The Program is only valid in the United States and U.S. Territories. The Program is not valid for Massachusetts, Michigan, Minnesota, or Rhode Island residents. This program is not valid where prohibited by law. Participating patients, physician offices, and hospitals are responsible for reporting the receipt of all Program benefits as may be required, to any insurer, health plan, or other third party who pays for or reimburses any part of the testing fees using the Program. This program is not health insurance or a benefit plan. The patient or guardian must be 18 years or older to receive Program benefits.
This Program is void if the program benefit (eg. physical card, virtual card, etc) is reproduced and where prohibited by law. It is only valid for treatment with ROZLYTREK and only valid in the U.S. and U.S. Territories. Genentech, Inc. reserves the right to rescind, revoke, or amend the program without notice at any time. The patient, guardian, prescriber, hospital and any other person using or administering the Program agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer of this program. Additional Terms and Conditions apply. Please visit rozlytrek.com/hcp/resources-downloads.html for the full list of Terms and Conditions.

Genentech does not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from Genentech BioOncology Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech’s endorsement or financial support. There may be other foundations to support the patient’s disease state.

§To be eligible for free ROZLYTREK from the Genentech Patient Foundation, insured patients who have coverage for their medicine must have exhausted all other forms of patient assistance (including the ROZLYTREK Co-pay Program and support from independent co-pay assistance foundations) and must meet certain financial criteria. Uninsured patients and insured patients without coverage for their medicine must meet different financial criteria.

What is Genentech BioOncology Access Solutions?

How can I find what options are available for my patient?

How can I enroll my patients?

Once enrolled in a program, how long will my patient keep receiving assistance?

What if I have questions about your programs?